NEUROCRINE BIOSCIENCES INC

Ticker: NBIX CUSIP: 64125C109 Class: EQTY

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 52,666 Value ($000) $7,470 Avg Close $144.87 Range $133.61 - $160.18

Q3 2025

Shares 54,861 Value ($000) $7,701 Avg Close $135.50 Range $123.67 - $148.00

Q2 2025

Shares 57,027 Value ($000) $7,168 Avg Close $114.68 Range $84.23 - $130.46

Q1 2025

Shares 59,707 Value ($000) $6,604 Avg Close $126.68 Range $105.18 - $154.61

Q4 2024

Shares 61,442 Value ($000) $8,387 Avg Close $123.68 Range $110.95 - $140.00

Q3 2024

Shares 56,707 Value ($000) $6,534 Avg Close $137.09 Range $114.08 - $157.98

Q2 2024

Shares 57,602 Value ($000) $7,930 Avg Close $137.14 Range $129.33 - $145.78

Q1 2024

Shares 58,604 Value ($000) $8,083 Avg Close $136.57 Range $128.00 - $148.37

Q4 2023

Shares 59,348 Value ($000) $7,820 Avg Close $115.11 Range $103.63 - $133.64

Q3 2023

Shares 59,968 Value ($000) $6,746 Avg Close $105.30 Range $93.28 - $119.29

Q2 2023

Shares 62,480 Value ($000) $5,892 Avg Close $97.71 Range $89.04 - $107.98

Q1 2023

Shares 63,032 Value ($000) $6,380 Avg Close $104.06 Range $92.89 - $125.02

Q4 2022

Shares 64,270 Value ($000) $7,676 Avg Close $117.13 Range $105.14 - $129.29

Q3 2022

Shares 65,335 Value ($000) $6,939 Avg Close $101.46 Range $91.53 - $109.26

Q2 2022

Shares 66,018 Value ($000) $6,435 Avg Close $92.29 Range $75.25 - $100.73

Q1 2022

Shares 65,509 Value ($000) $6,141 Avg Close $84.75 Range $71.88 - $95.87

Q4 2021

Shares 45,974 Value ($000) $3,916 Avg Close $91.99 Range $78.31 - $108.02

Q3 2021

Shares 45,469 Value ($000) $4,361 Avg Close $94.46 Range $84.77 - $101.43

Q2 2021

Shares 47,242 Value ($000) $4,598 Avg Close $95.85 Range $87.19 - $103.72

Q1 2021

Shares 48,526 Value ($000) $4,719 Avg Close $104.86 Range $87.37 - $120.27

Q1 2019

Shares 123 Value ($000) $11 Avg Close $83.58 Range $67.10 - $92.71

Q4 2018

Shares 122 Value ($000) $9 Avg Close $95.81 Range $64.72 - $125.59

Q3 2018

Shares 123 Value ($000) $15 Avg Close $113.46 Range $96.98 - $126.98

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	52,666	$7,470	$144.87	$133.61 - $160.18
Q3 2025	54,861	$7,701	$135.50	$123.67 - $148.00
Q2 2025	57,027	$7,168	$114.68	$84.23 - $130.46
Q1 2025	59,707	$6,604	$126.68	$105.18 - $154.61
Q4 2024	61,442	$8,387	$123.68	$110.95 - $140.00
Q3 2024	56,707	$6,534	$137.09	$114.08 - $157.98
Q2 2024	57,602	$7,930	$137.14	$129.33 - $145.78
Q1 2024	58,604	$8,083	$136.57	$128.00 - $148.37
Q4 2023	59,348	$7,820	$115.11	$103.63 - $133.64
Q3 2023	59,968	$6,746	$105.30	$93.28 - $119.29
Q2 2023	62,480	$5,892	$97.71	$89.04 - $107.98
Q1 2023	63,032	$6,380	$104.06	$92.89 - $125.02
Q4 2022	64,270	$7,676	$117.13	$105.14 - $129.29
Q3 2022	65,335	$6,939	$101.46	$91.53 - $109.26
Q2 2022	66,018	$6,435	$92.29	$75.25 - $100.73
Q1 2022	65,509	$6,141	$84.75	$71.88 - $95.87
Q4 2021	45,974	$3,916	$91.99	$78.31 - $108.02
Q3 2021	45,469	$4,361	$94.46	$84.77 - $101.43
Q2 2021	47,242	$4,598	$95.85	$87.19 - $103.72
Q1 2021	48,526	$4,719	$104.86	$87.37 - $120.27
Q1 2019	123	$11	$83.58	$67.10 - $92.71
Q4 2018	122	$9	$95.81	$64.72 - $125.59
Q3 2018	123	$15	$113.46	$96.98 - $126.98